Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia

Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia

Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaq...

Full description

Bibliographic Details
Main Authors: Gunar Günther, Lusia Mhuulu, Azaria Diergaardt, Viola Dreyer, Maria Moses, Kaarna Anyolo, Nunurai Ruswa, Mareli Claassens, Stefan Niemann, Emmanuel Nepolo
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2024-03-01
Series:Emerging Infectious Diseases
Subjects:
tuberculosis
TB
tuberculosis and other mycobacteria
bacteria
respiratory infections
bedaquiline
Online Access:https://wwwnc.cdc.gov/eid/article/30/3/24-0134_article

Internet

https://wwwnc.cdc.gov/eid/article/30/3/24-0134_article

Similar Items